Follow RSS for latest reports on this topicMuscular Dystrophy - Market Research and Reports

Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral muscular dystrophy, Limb-girdle muscular dystrophy, Myotonia congenita and Myotonic dystrophy.

Symptoms  can include progressive muscle weakness, delayed development of muscle motor skills, difficulting is using a group of muscles and possible falls,

In the absence of a cure, physical therapy (to maintain muscle tone), orthopedic appliances and corticosteroids can help avoid progression of the disease.

The prognosis is dependent on the type of dystrophy; Duchenne is deadly, but others can have complications such as cardiomyopathy and respiratory failure. 

Duchenne muscular dystrophy can be detected with about 95% accuracy by genetic studies performed during pregnancy, and genetic counseling is advised of there is a family history of the condition.

Source: Adapted from NIH

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma an [Report Updated: 24-04-2017]

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for 6 billion in 2015, and is anticipated to reach 9 billion by 2022, registering a CAGR of 6.8% from 2016 to 2022.nnOrphan drugs are used to treat rare (orphaned) diseases prevalent in a very small patie...Read More >>>


Published by: Allied Market Research

Prices Starting From:

Additional Searches

You may also like to search separately for: Muscular Dystrophy

We Stock...